Test Price
1,600 AED✅ Home Collection Available
HER-2/neu (Breast Cancer) Analysis in UAE | 1600 AED | 2026 DHA Guidelines
تحليل HER-2/neu (سرطان الثدي) في الإمارات | 1600 درهم | معتمد من هيئة الصحة بدبي
Clinical-Grade HER-2/neu FISH Analysis for Precise Breast Cancer Management
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Tumour Tissue Collection Coordination & Cold-Chain Transport; VIP Mobile Phlebotomy for companion blood tests.
- Clinical Guidance: Complimentary telephonic post-test result interpretation by our Oncology Expert, Dr. Prabhakar Reddy (DHA: 61713011).
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: تحليل دقيق لبروتين HER-2/neu باستخدام تقنية FISH لتحديد العلاج المناعي الهادف لسرطان الثدي، مطابق لمعايير هيئة الصحة بدبي.
Test Overview
HER-2/neu (Human Epidermal Growth Factor Receptor 2) FISH testing on breast tumour tissue definitively determines gene amplification status, an essential step for selecting targeted therapies like trastuzumab (Herceptin) in invasive breast carcinoma. Our UAE-based laboratory uses high-sensitivity Fluorescence In-Situ Hybridization to directly visualize HER2 gene copy numbers, resolving any equivocal immunohistochemistry (IHC) results with unmatched precision.
| Feature | Our HER-2/neu FISH Test | Closest Alternative (IHC 2+ Reflex) |
|---|---|---|
| Precision | Direct gene amplification (copy number) – definitive positive/negative | Semi‑quantitative protein expression – equivocal results possible |
| Methodology | FISH (Fluorescence In-Situ Hybridization) with dual-colour probes | IHC with reflex FISH only when borderline |
| Turnaround Time | 7–8 working days | 5–14 days (variable, lab dependent) |
Physician Insight & Safety Protocol
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Your current cancer treatment, including biologic agents, may influence test accuracy if not managed appropriately.
Safety Exclusion Criteria & Emergency Red Flags
- Inadequate or non‑representative tumour sample (a core biopsy or surgical specimen is mandatory).
- Prior neoadjuvant chemotherapy/anti‑HER2 therapy within 3 weeks may alter HER2 status; consult your oncologist for optimal repeat testing timing.
- If you experience sudden worsening pain, shortness of breath, or neurological symptoms (e.g., confusion, weakness), seek emergency care immediately — do not wait for test results.
Patient FAQ & Clinical Guidance
What does a HER-2/neu FISH positive result mean for my breast cancer treatment?
A positive FISH result indicates HER2 gene amplification, making your tumour eligible for targeted anti‑HER2 therapies such as trastuzumab, pertuzumab, or antibody‑drug conjugates, which significantly improve survival outcomes. النتيجة الإيجابية تعني أن العلاج الموجه ضد بروتين HER2 مناسب، مما يحسن الاستجابة العلاجية ويتحسن المآل.
Do I need a doctor’s prescription for this test in the UAE?
Yes, a doctor’s prescription is typically required; however, exceptions apply for patients planning to travel abroad, undergoing surgery, or pregnancy cases where a prescription may not be mandated — we recommend consulting our clinical team via WhatsApp at +971545488731. نعم، تحتاج إلى وصفة طبية إلا في حالات السفر للخارج أو العمليات الجراحية أو الحمل، يمكنك استشارة فريقنا.
How is the tumour sample collected and transported for HER-2/neu testing?
A formalin‑fixed paraffin‑embedded (FFPE) tumour tissue block or 4‑micron unstained slides are required; our logistics team provides cold‑chain (2‑8°C) specimen collection directly from the biopsy hospital, ensuring sample integrity until analysis. يتم جمع عينة النسيج الورمي وتثبيته في الفورمالين، ثم نقله ضمن سلسلة تبريد محكمة لضمان دقة التحليل.
UAE Regulatory Compliance & Accreditation
- Laboratory licensed by Dubai Health Authority (Facility License # 9834453).
- Compliant with UAE Federal Decree-Law No. 41 of 2024 (Art. 87) for clinical laboratory standards and UAE PDPL (Federal Decree-Law No. 45 of 2021) for data privacy.
- ISO 9001:2015 Certified – Quality Management System (Cert: INT/EGQ/2509DA/3139).
- Specialist involvement: Oncologists and Insurance Medical Examiners ensure appropriate utilisation.
- LOINC 49663-4: HER2 [Presence] in Breast tumor by FISH; ICD-10-CM 2026: Z15.01, C50.9, Z85.3 for accurate coding and reimbursement.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians